- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00182858
Tissue Procurement for Biomedical Research
The need to obtain human tissue for methods development and disease correlation is frequent in Biomedical Research Center laboratories. This protocol is designed to create the opportunity to obtain such tissue samples including: blood, urine, saliva, sweat, feces, hair and nail clippings, nasal scraping, muscle, fat, skin and taste buds. It may also include samples taken during a surgical procedure, including: fluid from around the spinal column, heart, lungs and abdomen; fat, muscle, connective tissue and organs (liver, bladder, heart, kidney and skin).
Information derived from such studies is for research purposes only and is not provided to the participants or their health care provider. Samples will be coded (no names) and identifying information linking the participant to the sample will be maintained in a secure location by the P.I. and Study Coordinator.
Participants will be 18 years or older and have been identified by the investigator and/or physician to have a condition of interest for exploratory studies related to the participant s illness or other feature that offers the possibility of creating information that leads to scientifically useful and important studies. Participants could also be healthy volunteers, willing to provide their samples. These samples could be requested by an investigator to be used as age, gender, race and/or ethnicity-matched controls or to calibrate or compare and contrast across lab equipment. Participants will be excluded if obtaining the sample would be over and above usual clinical care, would result in excessive blood loss, or the individual is unable to provide informed consent.
The expected outcome is to provide investigators with the opportunity to obtain tissues of interest for laboratory evaluation.
Study Overview
Status
Conditions
Detailed Description
The need to obtain human tissue for methods development and disease correlation is frequent in Biomedical Research Center laboratories. This protocol is designed to create the opportunity to obtain such tissue samples including: blood, urine, saliva, sweat, feces, hair and nail clippings, nasal scraping, muscle, fat, skin and taste buds. It may also include samples taken during a surgical procedure, including: fluid from around the spinal column, heart, lungs and abdomen; fat, muscle, connective tissue and organs (liver, bladder, heart, kidney and skin).
Information derived from such studies is for research purposes only and is not provided to the participants or their health care provider. Samples will be coded (no names) and identifying information linking the participant to the sample will be maintained in a secure location by the P.I. and Study Coordinator.
Participants will be 18 years or older and have been identified by the investigator and/or physician to have a condition of interest for exploratory studies related to the participant s illness or other feature that offers the possibility of creating information that leads to scientifically useful and important studies. Participants could also be healthy volunteers, willing to provide their samples. These samples could be requested by an investigator to be used as age, gender, race and/or ethnicity-matched controls or to calibrate or compare and contrast across lab equipment. Participants will be excluded if obtaining the sample, would result in excessive blood loss, or the individual is unable to provide informed consent.
The expected outcome is to provide investigators with the opportunity to obtain tissues of interest for laboratory evaluation.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Josephine M Egan, M.D.
- Phone Number: (410) 558-8414
- Email: eganj@mail.nih.gov
Study Contact Backup
- Name: Denise L Melvin, R.N.
- Phone Number: (410) 350-3924
- Email: melvinde@mail.nih.gov
Study Locations
-
-
Maryland
-
Baltimore, Maryland, United States, 21224
- Recruiting
- National Institute of Aging, Clinical Research Unit
-
Contact:
- NIA Studies Recruitment
- Phone Number: 410-350-3941
- Email: niastudiesrecruitment@mail.nih.gov
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
- INCLUSION CRITERIA:
- Age 18 or older.
- Identified by the investigator , researcher, or physician to have a condition of interest for exploratory studies related to the participant s illness or other feature that offers the possibility of generation of hypotheses for future study.
- Healthy volunteers, willing to provide their samples.
EXCLUSION CRITERIA:
- The participant would be subjected to diagnostic and/or therapeutic procedures that are not necessary for clinical management.
- Excessive blood loss if this phlebotomy plus other research participation and/or clinical evaluation will result in blood loss of greater than 1 unit (400 ml, 1 pint) over an 8-week period.
- Inability to give informed consent.
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Retrospective
Cohorts and Interventions
Group / Cohort |
---|
1
Participants will be 18 years or older that are Healthy Volunteers or have been identified by the investigator and/or physician to have a condition of interest for exploratory studies related to the participant s illness or other feature that offers the possibility of creating information that leads to scientifically useful and important studies.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Provide the investigators the opportunity to obtain tissues for laboratory evaluation with the goal of either better understanding a disease or design a scientific study to better understand or treat a disease.
Time Frame: Ongoing
|
The goal is to assist in either the better understanding of a disease or to design a scientific study to better understand or treat a disease.
|
Ongoing
|
Collaborators and Investigators
Investigators
- Principal Investigator: Josephine M Egan, M.D., National Institute on Aging (NIA)
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 999903322
- 03-AG-N322
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Normal Volunteers
-
Syndax PharmaceuticalsCompletedHealthy Volunteers | Volunteers | Normal Volunteers | Human VolunteersUnited States
-
Repros Therapeutics Inc.Completed
-
Syndax PharmaceuticalsCompletedHealthy Volunteers | Volunteers | Normal Volunteers | Human VolunteersUnited States
-
Aerie PharmaceuticalsCompleted
-
Chonbuk National University HospitalCompletedNormal VolunteersKorea, Republic of
-
USWM, LLC (dba US WorldMeds)National Institute on Drug Abuse (NIDA)Completed
-
Bausch Health Americas, Inc.Completed
-
USWM, LLC (dba US WorldMeds)National Institute on Drug Abuse (NIDA)Completed